Loading…

Interaction of the Molecular Chaperone αB-Crystallin with α-Synuclein: Effects on Amyloid Fibril Formation and Chaperone Activity

α-Synuclein is a pre-synaptic protein, the function of which is not completely understood, but its pathological form is involved in neurodegenerative diseases. In vitro, α-synuclein spontaneously forms amyloid fibrils. Here, we report that αB-crystallin, a molecular chaperone found in Lewy bodies th...

Full description

Saved in:
Bibliographic Details
Published in:Journal of molecular biology 2004-07, Vol.340 (5), p.1167-1183
Main Authors: Rekas, Agata, Adda, Christopher G, Andrew Aquilina, J, Barnham, Kevin J, Sunde, Margaret, Galatis, Denise, Williamson, Nicholas A, Masters, Colin L, Anders, Robin F, Robinson, Carol V, Cappai, Roberto, Carver, John A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c326t-daaba5a0ea989be16eb82af0cccedf2231fe67f0f75fb60f8baa5f9753201aa83
cites cdi_FETCH-LOGICAL-c326t-daaba5a0ea989be16eb82af0cccedf2231fe67f0f75fb60f8baa5f9753201aa83
container_end_page 1183
container_issue 5
container_start_page 1167
container_title Journal of molecular biology
container_volume 340
creator Rekas, Agata
Adda, Christopher G
Andrew Aquilina, J
Barnham, Kevin J
Sunde, Margaret
Galatis, Denise
Williamson, Nicholas A
Masters, Colin L
Anders, Robin F
Robinson, Carol V
Cappai, Roberto
Carver, John A
description α-Synuclein is a pre-synaptic protein, the function of which is not completely understood, but its pathological form is involved in neurodegenerative diseases. In vitro, α-synuclein spontaneously forms amyloid fibrils. Here, we report that αB-crystallin, a molecular chaperone found in Lewy bodies that are characteristic of Parkinson's disease (PD), is a potent in vitro inhibitor of α-synuclein fibrillization, both of wild-type and the two mutant forms (A30P and A53T) that cause familial, early onset PD. In doing so, large irregular aggregates of α-synuclein and αB-crystallin are formed implying that αB-crystallin redirects α-synuclein from a fibril-formation pathway towards an amorphous aggregation pathway, thus reducing the amount of physiologically stable amyloid deposits in favor of easily degradable amorphous aggregates. α-Synuclein acts as a molecular chaperone to prevent the stress-induced, amorphous aggregation of target proteins. Compared to wild-type α-synuclein, both mutant forms have decreased chaperone activity in vitro against the aggregation of reduced insulin at 37 °C and the thermally induced aggregation of βL-crystallin at 60 °C. Wild-type α-synuclein abrogates the chaperone activity of αB-crystallin to prevent the precipitation of reduced insulin. Interaction between these two chaperones and formation of a complex are also indicated by NMR spectroscopy, size-exclusion chromatography and mass spectrometry. In summary, α-synuclein and αB-crystallin interact readily with each other and affect each other's properties, in particular α-synuclein fibril formation and αB-crystallin chaperone action.
doi_str_mv 10.1016/j.jmb.2004.05.054
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17887121</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S002228360400631X</els_id><sourcerecordid>17887121</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-daaba5a0ea989be16eb82af0cccedf2231fe67f0f75fb60f8baa5f9753201aa83</originalsourceid><addsrcrecordid>eNp9UM1uEzEQthBIhMIDcPOJ24axN7vrwClETVupVQ-0Z2vWO1Ycee1gb4r2zBPxIjwTLuHACemTRhp9PzMfY-8FLAWI9uNheRj7pQRYLaEpWL1gCwFqXam2Vi_ZAkDKSqq6fc3e5HwAgKZeqQX7cRMmSmgmFwOPlk974nfRkzl5THy7xyOlGIj_-vml2qY5T-i9C_y7m_ZlV32dw8l4cuETv7SWzJR58dmMs49u4DvXJ-f5LqYR_wRgGP7x3JTUJzfNb9kriz7Tu7_zgj3uLh-219Xt_dXNdnNbmVq2UzUg9tggEK7VuifRUq8kWjDG0GClrIWltrNgu8b2LVjVIzZ23TW1BIGo6gv24ex7TPHbifKkR5cNeY-B4ilr0SnVCSkKUZyJJsWcE1l9TG7ENGsB-rlufdClbv1ct4amYFU0n88aKh88OUo6G0ehnOZS6UUP0f1H_RsE44zt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17887121</pqid></control><display><type>article</type><title>Interaction of the Molecular Chaperone αB-Crystallin with α-Synuclein: Effects on Amyloid Fibril Formation and Chaperone Activity</title><source>ScienceDirect Freedom Collection</source><creator>Rekas, Agata ; Adda, Christopher G ; Andrew Aquilina, J ; Barnham, Kevin J ; Sunde, Margaret ; Galatis, Denise ; Williamson, Nicholas A ; Masters, Colin L ; Anders, Robin F ; Robinson, Carol V ; Cappai, Roberto ; Carver, John A</creator><creatorcontrib>Rekas, Agata ; Adda, Christopher G ; Andrew Aquilina, J ; Barnham, Kevin J ; Sunde, Margaret ; Galatis, Denise ; Williamson, Nicholas A ; Masters, Colin L ; Anders, Robin F ; Robinson, Carol V ; Cappai, Roberto ; Carver, John A</creatorcontrib><description>α-Synuclein is a pre-synaptic protein, the function of which is not completely understood, but its pathological form is involved in neurodegenerative diseases. In vitro, α-synuclein spontaneously forms amyloid fibrils. Here, we report that αB-crystallin, a molecular chaperone found in Lewy bodies that are characteristic of Parkinson's disease (PD), is a potent in vitro inhibitor of α-synuclein fibrillization, both of wild-type and the two mutant forms (A30P and A53T) that cause familial, early onset PD. In doing so, large irregular aggregates of α-synuclein and αB-crystallin are formed implying that αB-crystallin redirects α-synuclein from a fibril-formation pathway towards an amorphous aggregation pathway, thus reducing the amount of physiologically stable amyloid deposits in favor of easily degradable amorphous aggregates. α-Synuclein acts as a molecular chaperone to prevent the stress-induced, amorphous aggregation of target proteins. Compared to wild-type α-synuclein, both mutant forms have decreased chaperone activity in vitro against the aggregation of reduced insulin at 37 °C and the thermally induced aggregation of βL-crystallin at 60 °C. Wild-type α-synuclein abrogates the chaperone activity of αB-crystallin to prevent the precipitation of reduced insulin. Interaction between these two chaperones and formation of a complex are also indicated by NMR spectroscopy, size-exclusion chromatography and mass spectrometry. In summary, α-synuclein and αB-crystallin interact readily with each other and affect each other's properties, in particular α-synuclein fibril formation and αB-crystallin chaperone action.</description><identifier>ISSN: 0022-2836</identifier><identifier>EISSN: 1089-8638</identifier><identifier>DOI: 10.1016/j.jmb.2004.05.054</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>amyloid ; chaperone ; protein aggregation ; α-synuclein ; αB-crystallin</subject><ispartof>Journal of molecular biology, 2004-07, Vol.340 (5), p.1167-1183</ispartof><rights>2004 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-daaba5a0ea989be16eb82af0cccedf2231fe67f0f75fb60f8baa5f9753201aa83</citedby><cites>FETCH-LOGICAL-c326t-daaba5a0ea989be16eb82af0cccedf2231fe67f0f75fb60f8baa5f9753201aa83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Rekas, Agata</creatorcontrib><creatorcontrib>Adda, Christopher G</creatorcontrib><creatorcontrib>Andrew Aquilina, J</creatorcontrib><creatorcontrib>Barnham, Kevin J</creatorcontrib><creatorcontrib>Sunde, Margaret</creatorcontrib><creatorcontrib>Galatis, Denise</creatorcontrib><creatorcontrib>Williamson, Nicholas A</creatorcontrib><creatorcontrib>Masters, Colin L</creatorcontrib><creatorcontrib>Anders, Robin F</creatorcontrib><creatorcontrib>Robinson, Carol V</creatorcontrib><creatorcontrib>Cappai, Roberto</creatorcontrib><creatorcontrib>Carver, John A</creatorcontrib><title>Interaction of the Molecular Chaperone αB-Crystallin with α-Synuclein: Effects on Amyloid Fibril Formation and Chaperone Activity</title><title>Journal of molecular biology</title><description>α-Synuclein is a pre-synaptic protein, the function of which is not completely understood, but its pathological form is involved in neurodegenerative diseases. In vitro, α-synuclein spontaneously forms amyloid fibrils. Here, we report that αB-crystallin, a molecular chaperone found in Lewy bodies that are characteristic of Parkinson's disease (PD), is a potent in vitro inhibitor of α-synuclein fibrillization, both of wild-type and the two mutant forms (A30P and A53T) that cause familial, early onset PD. In doing so, large irregular aggregates of α-synuclein and αB-crystallin are formed implying that αB-crystallin redirects α-synuclein from a fibril-formation pathway towards an amorphous aggregation pathway, thus reducing the amount of physiologically stable amyloid deposits in favor of easily degradable amorphous aggregates. α-Synuclein acts as a molecular chaperone to prevent the stress-induced, amorphous aggregation of target proteins. Compared to wild-type α-synuclein, both mutant forms have decreased chaperone activity in vitro against the aggregation of reduced insulin at 37 °C and the thermally induced aggregation of βL-crystallin at 60 °C. Wild-type α-synuclein abrogates the chaperone activity of αB-crystallin to prevent the precipitation of reduced insulin. Interaction between these two chaperones and formation of a complex are also indicated by NMR spectroscopy, size-exclusion chromatography and mass spectrometry. In summary, α-synuclein and αB-crystallin interact readily with each other and affect each other's properties, in particular α-synuclein fibril formation and αB-crystallin chaperone action.</description><subject>amyloid</subject><subject>chaperone</subject><subject>protein aggregation</subject><subject>α-synuclein</subject><subject>αB-crystallin</subject><issn>0022-2836</issn><issn>1089-8638</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp9UM1uEzEQthBIhMIDcPOJ24axN7vrwClETVupVQ-0Z2vWO1Ycee1gb4r2zBPxIjwTLuHACemTRhp9PzMfY-8FLAWI9uNheRj7pQRYLaEpWL1gCwFqXam2Vi_ZAkDKSqq6fc3e5HwAgKZeqQX7cRMmSmgmFwOPlk974nfRkzl5THy7xyOlGIj_-vml2qY5T-i9C_y7m_ZlV32dw8l4cuETv7SWzJR58dmMs49u4DvXJ-f5LqYR_wRgGP7x3JTUJzfNb9kriz7Tu7_zgj3uLh-219Xt_dXNdnNbmVq2UzUg9tggEK7VuifRUq8kWjDG0GClrIWltrNgu8b2LVjVIzZ23TW1BIGo6gv24ex7TPHbifKkR5cNeY-B4ilr0SnVCSkKUZyJJsWcE1l9TG7ENGsB-rlufdClbv1ct4amYFU0n88aKh88OUo6G0ehnOZS6UUP0f1H_RsE44zt</recordid><startdate>20040723</startdate><enddate>20040723</enddate><creator>Rekas, Agata</creator><creator>Adda, Christopher G</creator><creator>Andrew Aquilina, J</creator><creator>Barnham, Kevin J</creator><creator>Sunde, Margaret</creator><creator>Galatis, Denise</creator><creator>Williamson, Nicholas A</creator><creator>Masters, Colin L</creator><creator>Anders, Robin F</creator><creator>Robinson, Carol V</creator><creator>Cappai, Roberto</creator><creator>Carver, John A</creator><general>Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20040723</creationdate><title>Interaction of the Molecular Chaperone αB-Crystallin with α-Synuclein: Effects on Amyloid Fibril Formation and Chaperone Activity</title><author>Rekas, Agata ; Adda, Christopher G ; Andrew Aquilina, J ; Barnham, Kevin J ; Sunde, Margaret ; Galatis, Denise ; Williamson, Nicholas A ; Masters, Colin L ; Anders, Robin F ; Robinson, Carol V ; Cappai, Roberto ; Carver, John A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-daaba5a0ea989be16eb82af0cccedf2231fe67f0f75fb60f8baa5f9753201aa83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>amyloid</topic><topic>chaperone</topic><topic>protein aggregation</topic><topic>α-synuclein</topic><topic>αB-crystallin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rekas, Agata</creatorcontrib><creatorcontrib>Adda, Christopher G</creatorcontrib><creatorcontrib>Andrew Aquilina, J</creatorcontrib><creatorcontrib>Barnham, Kevin J</creatorcontrib><creatorcontrib>Sunde, Margaret</creatorcontrib><creatorcontrib>Galatis, Denise</creatorcontrib><creatorcontrib>Williamson, Nicholas A</creatorcontrib><creatorcontrib>Masters, Colin L</creatorcontrib><creatorcontrib>Anders, Robin F</creatorcontrib><creatorcontrib>Robinson, Carol V</creatorcontrib><creatorcontrib>Cappai, Roberto</creatorcontrib><creatorcontrib>Carver, John A</creatorcontrib><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Journal of molecular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rekas, Agata</au><au>Adda, Christopher G</au><au>Andrew Aquilina, J</au><au>Barnham, Kevin J</au><au>Sunde, Margaret</au><au>Galatis, Denise</au><au>Williamson, Nicholas A</au><au>Masters, Colin L</au><au>Anders, Robin F</au><au>Robinson, Carol V</au><au>Cappai, Roberto</au><au>Carver, John A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interaction of the Molecular Chaperone αB-Crystallin with α-Synuclein: Effects on Amyloid Fibril Formation and Chaperone Activity</atitle><jtitle>Journal of molecular biology</jtitle><date>2004-07-23</date><risdate>2004</risdate><volume>340</volume><issue>5</issue><spage>1167</spage><epage>1183</epage><pages>1167-1183</pages><issn>0022-2836</issn><eissn>1089-8638</eissn><abstract>α-Synuclein is a pre-synaptic protein, the function of which is not completely understood, but its pathological form is involved in neurodegenerative diseases. In vitro, α-synuclein spontaneously forms amyloid fibrils. Here, we report that αB-crystallin, a molecular chaperone found in Lewy bodies that are characteristic of Parkinson's disease (PD), is a potent in vitro inhibitor of α-synuclein fibrillization, both of wild-type and the two mutant forms (A30P and A53T) that cause familial, early onset PD. In doing so, large irregular aggregates of α-synuclein and αB-crystallin are formed implying that αB-crystallin redirects α-synuclein from a fibril-formation pathway towards an amorphous aggregation pathway, thus reducing the amount of physiologically stable amyloid deposits in favor of easily degradable amorphous aggregates. α-Synuclein acts as a molecular chaperone to prevent the stress-induced, amorphous aggregation of target proteins. Compared to wild-type α-synuclein, both mutant forms have decreased chaperone activity in vitro against the aggregation of reduced insulin at 37 °C and the thermally induced aggregation of βL-crystallin at 60 °C. Wild-type α-synuclein abrogates the chaperone activity of αB-crystallin to prevent the precipitation of reduced insulin. Interaction between these two chaperones and formation of a complex are also indicated by NMR spectroscopy, size-exclusion chromatography and mass spectrometry. In summary, α-synuclein and αB-crystallin interact readily with each other and affect each other's properties, in particular α-synuclein fibril formation and αB-crystallin chaperone action.</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.jmb.2004.05.054</doi><tpages>17</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2836
ispartof Journal of molecular biology, 2004-07, Vol.340 (5), p.1167-1183
issn 0022-2836
1089-8638
language eng
recordid cdi_proquest_miscellaneous_17887121
source ScienceDirect Freedom Collection
subjects amyloid
chaperone
protein aggregation
α-synuclein
αB-crystallin
title Interaction of the Molecular Chaperone αB-Crystallin with α-Synuclein: Effects on Amyloid Fibril Formation and Chaperone Activity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A43%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interaction%20of%20the%20Molecular%20Chaperone%20%CE%B1B-Crystallin%20with%20%CE%B1-Synuclein:%20Effects%20on%20Amyloid%20Fibril%20Formation%20and%20Chaperone%20Activity&rft.jtitle=Journal%20of%20molecular%20biology&rft.au=Rekas,%20Agata&rft.date=2004-07-23&rft.volume=340&rft.issue=5&rft.spage=1167&rft.epage=1183&rft.pages=1167-1183&rft.issn=0022-2836&rft.eissn=1089-8638&rft_id=info:doi/10.1016/j.jmb.2004.05.054&rft_dat=%3Cproquest_cross%3E17887121%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c326t-daaba5a0ea989be16eb82af0cccedf2231fe67f0f75fb60f8baa5f9753201aa83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17887121&rft_id=info:pmid/&rfr_iscdi=true